Health Care [ 4/12 ] | Health Care Providers & Services [ 39/74 ]
NASDAQ | Common Stock
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.
It provides diagnostic blood cancer testing services.
The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
It offers biomarker testing and clinical project services to bio-pharma customers.
Precipio, Inc. is based in New Haven, Connecticut.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 31, 25 | -0.24 Increased by +76.50% | - |
| Nov 11, 24 | -0.42 Decreased by -369.89% | - |
| Aug 13, 24 | -0.83 Decreased by -541.23% | - |
| May 14, 24 | 0.65 Increased by +751.40% | - |
| Nov 13, 23 | -1.04 Decreased by -642.86% | -1.21 Increased by +14.05% |
| Aug 11, 23 | -0.09 Increased by 0.00% | -0.10 Increased by +10.00% |
| May 12, 23 | -0.13 Decreased by -85.71% | -0.13 |
| Mar 30, 23 | -0.10 Decreased by -11.11% | -0.14 Increased by +28.57% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 5.45 M Increased by +25.90% | -365.00 K Decreased by -139.46% | Decreased by -6.70% Decreased by -131.34% |
| Sep 30, 24 | 4.60 M Increased by +23.03% | -626.00 K Increased by +56.98% | Decreased by -13.61% Increased by +65.03% |
| Jun 30, 24 | 4.44 M Increased by +25.70% | -1.22 M Increased by +46.79% | Decreased by -27.47% Increased by +57.67% |
| Mar 31, 24 | 3.43 M Increased by +21.83% | -2.08 M Increased by +31.39% | Decreased by -60.58% Increased by +43.68% |
| Dec 31, 23 | 4.33 M Increased by +81.05% | 925.00 K Increased by +140.08% | Increased by +21.37% Increased by +122.14% |
| Sep 30, 23 | 3.74 M Increased by +68.76% | -1.46 M Increased by +53.41% | Decreased by -38.92% Increased by +72.39% |
| Jun 30, 23 | 3.53 M Increased by +49.77% | -2.29 M Decreased by -24.01% | Decreased by -64.90% Increased by +17.20% |
| Mar 31, 23 | 2.82 M Increased by +15.12% | -3.03 M Increased by +30.58% | Decreased by -107.56% Increased by +39.70% |